Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel XR Monotherapy in Acute Bipolar Depression
NCT00422214Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in bipolar disorder (BD), sponsored by AstraZeneca. Started Dec 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00422214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422214.